Aclaris Therapeutics, Inc.
ACRS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$14,614 | -$15,429 | -$15,085 | -$96,552 |
| Dep. & Amort. | $210 | $114 | $128 | $143 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $3,063 | $3,535 | $2,860 |
| Change in WC | $612 | $759 | -$1,935 | -$994 |
| Other Non-Cash | $2,860 | $1,500 | $300 | $85,605 |
| Operating Cash Flow | -$10,932 | -$9,993 | -$13,057 | -$8,938 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$23 | -$21 | -$43 | -$35,810 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$5,198 | -$19,930 | -$9,996 | -$70,427 |
| Inv. Sales/Matur. | $19,051 | $24,998 | $29,991 | $17,514 |
| Other Inv. Act. | $0 | $0 | -$833 | $0 |
| Investing Cash Flow | $13,830 | $5,047 | $19,119 | -$88,723 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $74,913 |
| Stock Repurch. | $0 | -$9 | -$275 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$3,044 | $0 | $0 | -$333 |
| Financing Cash Flow | -$3,044 | -$9 | -$275 | $74,580 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$146 | -$4,955 | $5,787 | -$23,081 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $25,402 | $30,357 | $24,570 | $47,651 |
| End Cash | $25,256 | $25,402 | $30,357 | $24,570 |
| Free Cash Flow | -$10,955 | -$10,014 | -$13,100 | -$44,748 |